Synthesis and antiproliferative evaluation of certain pyrido[3,2-g]quinoline derivatives

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 22, 2006, Pages 7370-7376

  Li, Shu Yu ^a   Chen, Yeh Long ^a   Wang, Chihuei ^a   Tzeng, Cherng Chyi ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antiproliferative; Pyrido 3,2 g quinoline

Indexed keywords

4,6 DIETHOXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLIC ACID; 4,6 DIHYDROXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXAMIDE; 4,6 DIHYDROXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLIC ACID; 4,6 DIHYDROXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLIC ACID BIS ETHYLAMIDE; 4,6 DIHYDROXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLIC ACID BIS METHYLAMIDE; 4,6 DIMETHOXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLIC ACID; DIETHYL 10 METHYL 4,6 BISPHENYLAMINOPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 BIS (3 DIMETHYLAMINOPROPYLAMINO) 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 BIS(2 DIMETHYLAMINOETHYLAMINO) 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 BIS(4 CHLOROPHENYLAMINO) 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 BIS(4 METHOXYPHENYLAMINO) 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 BISMETHYLAMINO 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 DIAMINO 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 DICHLORO 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 DIETHOXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 DIHYDROXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; DIETHYL 4,6 DIMETHOXY 10 METHYLPYRIDO[3,2 G]QUINOLINE 3,7 DICARBOXYLATE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; FLOW CYTOMETRY; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; MALE; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

ANTIMITOTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MOLECULAR STRUCTURE; PYRIDINES; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33749234366     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.07.030     Document Type: Article

References (17)

1. Imperial Chemical Industries Ltd, Germany Patent No. DE2220294, 1972.
2. Fang K.C., Chen Y.L., Sheu J.Y., Wang T.C., and Tzeng C.C. J. Med. Chem. 43 (2000) 3809
3. Chen Y.L., Fang K.C., Sheu J.Y., Hsu S.L., and Tzeng C.C. J. Med. Chem. 44 (2001) 2374
4. Tzeng C.C., and Chen Y.L. Chin. Pharm. J. 54 (2002) 229
5. Sheu J.Y., Chen Y.L., Tzeng C.C., Hsu S.L., Fang K.C., and Wang T.C. Helv. Chim. Acta 86 (2003) 2481
6. Marians K.J., and Hiasa H. J. Biol. Chem. 272 (1997) 9401
7. Tabarrini O., Cecchetti V., Fravolini A., Nocentini G., Barzi A., Sabatini S., Miao H., and Sissi C. J. Med. Chem 42 (1999) 2136
8. Hsu S.L., Chen Y.L., and Tzeng C.C. Heterocycles 63 (2004) 529
9. Baguley B.C., Denny W.A., Atwell G.J., and Cain B.F. J. Med. Chem 24 (1981) 520
10. Hartley J.A., Reszka K., Zuo E.T., Wilson W.D., Morgan A.R., and Lown J.W. Mol. Pharmacol. 33 (1988) 265
11. Denny W.A. Anti-Cancer Drug Des. 4 (1989) 241
12. Costes N., Deit H.L., Michel S., Tillequin F., Koch M., Pfeiffer B., Renard P., Leonce S., Guilbaud N., Kraus-Berthier L., Pierre A., and Atassi G. J. Med. Chem 43 (2000) 2395
13. Zhao Y.L., Chen Y.L., Chang F.S., and Tzeng C.C. Eur. J. Med. Chem 40 (2005) 792
14. Chen Y.L., Chen I.L., Wang T.C., Han C.H., and Tzeng C.C. Eur. J. Med. Chem 40 (2005) 928
15. Chen Y.L., Huang C.J., Huang Z.Y., Tseng C.H., Chang F.S., Yang S.H., Lin S.R., and Tzeng C.C. Bioorg. Med. Chem 14 (2006) 3098
16. Marcos A., Pedregal C., and Avendano C. Tetrahedron 50 (1994) 12941
17. Gray G.D., and Wickstrom E. Biotechniques 21 (1996) 780